Gene-based therapy may slow development of life-threatening heart condition

A new study in mice shows that replacement of a dysfunctional gene could prolong survival in some people with arrhythmogenic right ventricular cardiomyopathy (ARVC), a rare inherited disorder in which the muscular walls of the heart progressively weaken and put patients at risk of dangerous irregular heartbeats.

Leave a Comment

Your email address will not be published. Required fields are marked *

Shopping Cart